The analysis suggests that regulatory initiatives, particularly the US Biosecure Act, could potentially accelerate this growth trajectory into the high teens, pushing the industry's value to USD 22 ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

The global Medical Device Contract Manufacturing market size was $73.61 billion in 2023 and is projected to reach $81.19 ...

Waaree Energies: Waaree Energies has won an order to supply 362.5 megawatt peak (MWp) of solar photovoltaic (PV) modules from ...

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

Biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) met Wall Street’s revenue expectations in Q4 CY2024, but sales were flat year on year at $167.5 million. The company’s outlook for ...

Chemical process enhances room temperature stability - - Provisional patent applications filed - PURCHASE, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or ...

We are thrilled to have Patrick step into this pivotal role,” said Benedikt von Braunmühl, CEO of Rentschler Biopharma. “Patrick’s in-depth understanding of our clients’ needs, coupled with his ...

Carbogen Amcis has appointed Stephan Fritschi, who is currently serving as the company’s Chief Alliance Officer and Deputy ...